valinomycin and Mast-Cell-Sarcoma

valinomycin has been researched along with Mast-Cell-Sarcoma* in 1 studies

Other Studies

1 other study(ies) available for valinomycin and Mast-Cell-Sarcoma

ArticleYear
Mitochondrial DNA is not fragmented during apoptosis.
    The Journal of biological chemistry, 1992, Jun-05, Volume: 267, Issue:16

    We have exposed mouse thymocytes and P-815 mastocytoma cells to four different conditions reported to cause apoptosis: 1) incubation in the absence of mitogenic factors; 2) incubation in the presence of dexamethasone; 3) stimulation with external ATP; 4) treatment with high concentrations of the K+ ionophore valinomycin. These treatments caused DNA fragmentation to a varying extent in the two cell types. High stringency hybridization with a cDNA probe specific to a mitochondrial DNA sequence revealed that during apoptosis induced by lack of mitogenic factors, dexamethasone, or extracellular ATP, mitochondrial DNA was not fragmented. On the contrary, valinomycin caused extensive degradation of mitochondrial DNA. These results support the notion that DNA fragmentation during apoptosis is a specific nuclear event and suggest that other agents, such as valinomycin, may act less selectively.

    Topics: Adenosine Triphosphate; Animals; Autoradiography; Blotting, Southern; Cell Death; Cells, Cultured; Dexamethasone; DNA; DNA Probes; DNA, Mitochondrial; Electrophoresis, Agar Gel; Mast-Cell Sarcoma; Mice; Mice, Inbred BALB C; Mitogens; Molecular Sequence Data; Thymus Gland; Tumor Cells, Cultured; Valinomycin

1992